Role of beta-defensin 2 and interleukin-4 receptor as stroke outcome biomarkers

Copeptin adds prognostic information after ischemic stroke: Results from the CoRisk study

(2013) G. M. De Marchis et al.   NEUROLOGY

Influence of Acute Complications on Outcome 3 Months after Ischemic Stroke

(2013) Maike Miriam Grube et al.   PLoS One

Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke Thrombolysis

(2013) Jean-Philippe Desilles et al.   STROKE

Brain Natriuretic Peptide Is Associated with Worsening and Mortality in Acute Stroke Patients but Adds No Prognostic Value to Clinical Predictors of Outcome

(2012) J. Montaner et al.   CEREBROVASCULAR DISEASES

New Metrics for Assessing Diagnostic Potential of Candidate Biomarkers

(2012) J. W. Pickering et al.   Clinical Journal of the American Society of Nephrology

Predictors of Clinical Deterioration during Hospitalization following Acute Ischemic Stroke

(2012) Leng-Chieh Lin et al.   EUROPEAN NEUROLOGY

Cocktail Blood Biomarkers: Prediction of Clinical Outcomes in Patients with Acute Ischemic Stroke

(2012) Lili Zeng et al.   EUROPEAN NEUROLOGY

Hypoxia Triggers the Expression of Human   Defensin 2 and Antimicrobial Activity against Mycobacterium tuberculosis in Human Macrophages

(2012) D. Nickel et al.   JOURNAL OF IMMUNOLOGY

Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients

(2012) Romain Fragnoud et al.   Proteome Science

Genetic polymorphisms of human β-defensins in patients with ischemic stroke

(2011) Z. Tiszlavicz et al.   ACTA NEUROLOGICA SCANDINAVICA

Heart Disease and Stroke Statistics—2012 Update

(2011) et al.   CIRCULATION

Blood Biomarkers of Ischemic Stroke

(2011) Glen C. Jickling et al.   Neurotherapeutics

The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic Stroke

(2011) William Whiteley et al.   STROKE

The Temporal Profile of Inflammatory Markers and Mediators in Blood after Acute Ischemic Stroke Differs Depending on Stroke Outcome

(2010) H. Worthmann et al.   CEREBROVASCULAR DISEASES

Osteopontin predicts long-term functional outcome among ischemic stroke patients

(2010) M. Mendioroz et al.   JOURNAL OF NEUROLOGY

Use of DNA–Damaging Agents and RNA Pooling to Assess Expression Profiles Associated with BRCA1 and BRCA2 Mutation Status in Familial Breast Cancer Patients

(2010) Logan C. Walker et al.   PLoS Genetics

Endogenous Activated Protein C Predicts Hemorrhagic Transformation and Mortality after Tissue Plasminogen Activator Treatment in Stroke Patients

(2009) Maite Mendioroz et al.   CEREBROVASCULAR DISEASES

Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke

(2009) Paul Welsh et al.   CEREBROVASCULAR DISEASES

Intestinal ischaemia/reperfusion upregulates β-defensin-2 expression and causes acute lung injury in the rat

(2009) Ke-Xuan Liu et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL Fractionation

(2009) Emilie Ernoult et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Blood Markers for the Prognosis of Ischemic Stroke

(2009) William Whiteley et al.   STROKE

Hyperfibrinogenemia and Functional Outcome From Acute Ischemic Stroke

(2009) Gregory J. del Zoppo et al.   STROKE

Hemodynamic Factors and Perfusion Abnormalities in Early Neurological Deterioration

(2009) Josef A. Alawneh et al.   STROKE

Acute stroke unit care and early neurological deterioration in ischemic stroke

(2008) Jaume Roquer et al.   JOURNAL OF NEUROLOGY

Investigating sample pooling strategies for DIGE experiments to address biological variability

(2008) Natasha A. Karp et al.   PROTEOMICS